Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated:  4/15/2016
Georgetown University
mi
from
Washington,
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated: 4/15/2016
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated:  4/15/2016
Temple University
mi
from
Philadelphia, PA
Breast Health in Chinese American Women
A RCT to Promote Mammography Adherence Among Chinese Immigrant Women
Status: Enrolling
Updated: 4/15/2016
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Nashville, TN
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  4/20/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase I Trial of Weekly Paclitaxel in Combination With Bavituximab in Patients With Her-2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 4/20/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Component and Couple Analysis of Cancer Communications
Component and Couple Analysis of Cancer Communications
Status: Enrolling
Updated:  4/21/2016
The Hartford Hospital
mi
from
Hartford, CT
Component and Couple Analysis of Cancer Communications
Component and Couple Analysis of Cancer Communications
Status: Enrolling
Updated: 4/21/2016
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Component and Couple Analysis of Cancer Communications
Component and Couple Analysis of Cancer Communications
Status: Enrolling
Updated:  4/21/2016
M. D. Anderson
mi
from
Houston, TX
Component and Couple Analysis of Cancer Communications
Component and Couple Analysis of Cancer Communications
Status: Enrolling
Updated: 4/21/2016
M. D. Anderson
mi
from
Houston, TX
Click here to add this to my saved trials
Component and Couple Analysis of Cancer Communications
Component and Couple Analysis of Cancer Communications
Status: Enrolling
Updated:  4/21/2016
University of Wisconsin
mi
from
Madison, WI
Component and Couple Analysis of Cancer Communications
Component and Couple Analysis of Cancer Communications
Status: Enrolling
Updated: 4/21/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
Detroit, MI
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
Hackensack, NJ
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
New Brunswick, NJ
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
Seattle, WA
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Oral Bioavailability of Veliparib Extended Release Formulations in Subjects With Solid Tumors
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
Status: Enrolling
Updated:  5/4/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer
Status: Enrolling
Updated: 5/4/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
Status: Enrolling
Updated:  5/5/2016
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
Status: Enrolling
Updated: 5/5/2016
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Highlands Oncology Group Highlands Oncology Group (22)
mi
from
Fayetteville, AR
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Highlands Oncology Group Highlands Oncology Group (22)
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
mi
from
Anaheim, CA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
mi
from
Anaheim, CA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Los Angeles Hematology/Oncology Medical Group
mi
from
Los Angeles, CA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Los Angeles Hematology/Oncology Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
University of California at Los Angeles UCLA and TRIO Network
mi
from
Los Angeles, CA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
University of California at Los Angeles UCLA and TRIO Network
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
University of California Irvine UC Irvine Medical Center
mi
from
Orange, CA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
University of California Irvine UC Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
California Pacific Medical Center SC
mi
from
San Francisco, CA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
California Pacific Medical Center SC
mi
from
San Francisco, CA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
University of California San Francisco (UCSF) Medical Center
mi
from
San Francisco, CA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
University of California San Francisco (UCSF) Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
University of Connecticut Health Center
mi
from
Farmington, CT
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Southeastern Regional Medical Center
mi
from
Newnan, GA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Southeastern Regional Medical Center
mi
from
Newnan, GA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
OnCare Hawaii
mi
from
Aiea, HI
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
OnCare Hawaii
mi
from
Aiea, HI
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
North Shore University Health System NorthShore University
mi
from
Evanston, IL
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
North Shore University Health System NorthShore University
mi
from
Evanston, IL
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Oncology Specialists, SC Onc Specialists
mi
from
Park Ridge, IL
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Oncology Specialists, SC Onc Specialists
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
University of Maryland School of Medicine University of Maryland
mi
from
Baltimore, MD
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
University of Maryland School of Medicine University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Kaiser Permanente - Mid Atlantic Permanete Research Institut Kaiser Permanente Mid-Atlantic
mi
from
Rockville, MD
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Kaiser Permanente - Mid Atlantic Permanete Research Institut Kaiser Permanente Mid-Atlantic
mi
from
Rockville, MD
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Karmanos Cancer Institute Karmanos Cancer Institute (2)
mi
from
Detroit, MI
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Karmanos Cancer Institute Karmanos Cancer Institute (2)
mi
from
Detroit, MI
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Regional Cancer Care Associates Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Regional Cancer Care Associates Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2)
mi
from
Morristown, NJ
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2)
mi
from
Morristown, NJ
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
M. Francisco Gonzalez, MD.PA Hematology Oncology Center
mi
from
Columbia, SC
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
M. Francisco Gonzalez, MD.PA Hematology Oncology Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Oncology Consultants Oncology Consultants, P.A.
mi
from
Houston, TX
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Oncology Consultants Oncology Consultants, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(2)
mi
from
Houston, TX
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(2)
mi
from
Houston, TX
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Delta Oncology Associates Delta Hematology/Oncology
mi
from
Portsmouth, VA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Delta Oncology Associates Delta Hematology/Oncology
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Northwest Medical Specialties Northwest Medical - Puyallup
mi
from
Tacoma, WA
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Northwest Medical Specialties Northwest Medical - Puyallup
mi
from
Tacoma, WA
Click here to add this to my saved trials
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated:  5/5/2016
Saint Luke's Hospital/Marion Bloch Neuroscience Institute Cancer Institute
mi
from
Kansas City, MO
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
A Phase II, Single Arm Study of the Use of Steroid-based Mouthwash to Prevent Stomatitis in Postmenopausal Women With Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated With Everolimus Plus Exemestane
Status: Enrolling
Updated: 5/5/2016
Saint Luke's Hospital/Marion Bloch Neuroscience Institute Cancer Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation
Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation
Status: Enrolling
Updated:  5/9/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation
Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation
Status: Enrolling
Updated: 5/9/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
The Jewels in Our Genes Study - an African American Family Study of Breast Cancer
Search for Novel Breast Cancer Susceptibility Genes in Pedigrees of African Ancestry
Status: Enrolling
Updated:  5/10/2016
University at Buffalo
mi
from
Buffalo, NY
The Jewels in Our Genes Study - an African American Family Study of Breast Cancer
Search for Novel Breast Cancer Susceptibility Genes in Pedigrees of African Ancestry
Status: Enrolling
Updated: 5/10/2016
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction
A Comparison of Dermal Autograft to Commercially Available Dermal Allograft in Breast Reconstruction
Status: Enrolling
Updated:  5/10/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction
A Comparison of Dermal Autograft to Commercially Available Dermal Allograft in Breast Reconstruction
Status: Enrolling
Updated: 5/10/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients
Prospective Pilot Study Evaluating the Inter-relationships Between Sleep Disturbance, Fatigue, Pain, and Daytime Activity in Breast Cancer Patients Starting Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  5/10/2016
University of Michigan Health System
mi
from
Ann Arbor, MI
Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients
Prospective Pilot Study Evaluating the Inter-relationships Between Sleep Disturbance, Fatigue, Pain, and Daytime Activity in Breast Cancer Patients Starting Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 5/10/2016
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effects of Exemestane on Bone Strength
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  5/12/2016
University of California-Davis
mi
from
Sacramento, CA
Effects of Exemestane on Bone Strength
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 5/12/2016
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Effects of Exemestane on Bone Strength
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  5/12/2016
The Mayo Clinic
mi
from
Rochester, MN
Effects of Exemestane on Bone Strength
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 5/12/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Effects of Exemestane on Bone Strength
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  5/12/2016
University Health Network, TGH
mi
from
Toronto,
Effects of Exemestane on Bone Strength
Effects of Exemestane on Bone Strength in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 5/12/2016
University Health Network, TGH
mi
from
Toronto,
Click here to add this to my saved trials
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Status: Enrolling
Updated:  5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Status: Enrolling
Updated: 5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cocinar Para su Salud! (Cook for Your Life!)
Cocinar Para su Salud! (Cook for Your Life!): Implementing Dietary Change Among Hispanic Breast Cancer Survivors
Status: Enrolling
Updated:  5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Cocinar Para su Salud! (Cook for Your Life!)
Cocinar Para su Salud! (Cook for Your Life!): Implementing Dietary Change Among Hispanic Breast Cancer Survivors
Status: Enrolling
Updated: 5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Status: Enrolling
Updated:  5/19/2016
The Mayo Clinic
mi
from
Rochester, MN
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Status: Enrolling
Updated: 5/19/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
Helping the Mother With Breast Cancer Support Her Child
Status: Enrolling
Updated:  5/19/2016
Univ of Washington
mi
from
Seattle, WA
Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
Helping the Mother With Breast Cancer Support Her Child
Status: Enrolling
Updated: 5/19/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials